Abilify 15 mg 10 tablets

Abilify 15 mg ( Aripiprazole ) 10 tablets 1. Name of the medicinal product ABILIFY 5 mg tablets ABILIFY 10 mg tablets ABILIFY 15 mg tablets 4. Clinical particulars 4.1 Therapeutic indications ABILIFY is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older. ABILIFY is indicated for the treatment of moderate to severe manic episodes in Bipolar I Disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment (see section 5.1). ABILIFY is indicated for the treatment up to 12 weeks of moderate to severe manic episodes in Bipolar I Disorder in adolescents aged 13 years and older (see section 5.1).